SAMRAT PHARMACHEM
|
SAMRAT PHARMACHEM Last 5 Year Cashflow Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹2.52 Cr | ₹23 Cr | ₹24 Cr | ₹7.34 Cr | ₹5.79 Cr |
Adjustment | ₹0.03 Cr | ₹1.65 Cr | ₹1.19 Cr | ₹1.70 Cr | ₹1.39 Cr |
Changes In working Capital | ₹9.27 Cr | ₹-24 Cr | ₹-5.78 Cr | ₹-1.99 Cr | ₹-7.62 Cr |
Cash Flow after changes in Working Capital | ₹12 Cr | ₹0.06 Cr | ₹19 Cr | ₹7.05 Cr | ₹-0.45 Cr |
Cash Flow from Operating Activities | ₹9.41 Cr | ₹-9.44 Cr | ₹17 Cr | ₹4.80 Cr | ₹-1.33 Cr |
Cash Flow from Investing Activities | ₹-0.41 Cr | ₹-3.00 Cr | ₹-1.06 Cr | ₹-2.92 Cr | ₹-1.92 Cr |
Cash Flow from Financing Activities | ₹-11 Cr | ₹9.60 Cr | ₹-1.95 Cr | ₹-1.89 Cr | ₹2.00 Cr |
Net Cash Inflow / Outflow | ₹-2.19 Cr | ₹-2.84 Cr | ₹14 Cr | ₹-0.02 Cr | ₹-1.25 Cr |
Opening Cash & Cash Equivalents | ₹12 Cr | ₹15 Cr | ₹0.24 Cr | ₹0.26 Cr | ₹1.50 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹9.67 Cr | ₹12 Cr | ₹15 Cr | ₹0.24 Cr | ₹0.26 Cr |
Compare Cashflow Statement of peers of SAMRAT PHARMACHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAMRAT PHARMACHEM | ₹106.0 Cr | -11.2% | -18.4% | -17.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
SAMRAT PHARMACHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAMRAT PHARMACHEM | -11.2% |
-18.4% |
-17.5% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses